Low riskFDA DrugClass III

Fexofenadine 180 mg tablets recalled for failed impurity specifications

Sun Pharmaceutical Industries is recalling about 9,048 bottles of Fexofenadine Hydrochloride Tablets, USP 180 mg, distributed by Ohm Laboratories. The tablets failed impurities and degradation specifications. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls

What to do

  1. Stop using the affected tablets and set the bottles aside.
  2. Check the lot number and expiration date on the bottle. The affected lots are DNG0283A (exp 03/31/2027), and DNF0922A and DNF0923B (exp 10/31/2026).
  3. Confirm the NDC on the label is 66336-561-30. This recall covers 150-tablet bottles.
  4. The notice doesn't say how to get a refund or replacement; ask Ohm Laboratories or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
9,048 bottles
Illnesses reported
None reported
Manufactured in
2 Independence Way, N/A, Princeton, NJ, United States
Classification
Class III
Recall number
D-0654-2026

In the FDA's words

Description
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30 Failed Impurities/Degradation Specifications Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026 Distribution: U.S. Nationwide Affected quantity: 9,048 bottles
Hazard
Failed Impurities/Degradation Specifications

More from Sun Pharmaceutical

See all

Related topics

Industrial chemicalsDrugsSold nationwideMore from FDA Drug